This web only provides the extract of this article. If you want to read the figures and tables, please reference the PDF full text on Blackwell Synergy. Thank you.
- Original Article -
Age-dependent expression of the cystatin-related epididymal spermatogenic (Cres) gene in mouse testis and
epididymis
Qing Yuan1, Qiang-Su Guo1, Gail A. Cornwall2, Chen Xu1, Yi-Fei Wang1
1Department of Histology & Embryology, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China
2Departments of Cell Biology and Biochemistry, Texas Technology University Health Science Center, Lubbock, TX, USA
Abstract
Aim: To investigate the spatial and temporal expression of the cystatin-related epididymal spermatogenic
(Cres) gene in mouse testis and epididymis during postnatal development.
Methods: The QuantiGene assay and indirect
immunofluorescence technique were used to examine the
Cres mRNA and Cres protein level in mouse testis and epididymis
on postnatal days 14, 20, 22, 28, 35, 49, 70 and 420.
Results: (1) In both the testis and epididymis,
Cres mRNA was first detected on day 20, then it increased gradually from day 20 to day 70, and the high expression level maintained
till day 420. (2) In the testis, the Cres protein was exclusively localized to the elongating spermatids and was first
detected on day 22. The number of Cres-positive spermatids increased progressively till day 49. From day 49 to day
420, the number of Cres-positive cells was almost stable. (3) The Cres protein was first detected on day 20 in the
proximal caput epididymal epithelium. By day 35, the expression level of the Cres protein increased dramatically and
the high level was maintained till day 420. Moreover, the luminal fluid of the midcaput epididymis was also stained
Cres-positive from day 35 on. No Cres-positive staining was observed in distal caput, corpus and cauda epididymis
throughout. Conclusion: The Cres gene displays a specific age-dependent expression pattern in mouse testis and
epididymis on both the mRNA and protein level.
(Asian J Androl 2007 May; 9: 305_311)
Keywords: cystatin-related epididymal spermatogenic gene; spermatogenesis; sperm maturation; development
Correspondence to: Prof. Yi-Fei Wang, Department of Histology and Embryology, Shanghai Jiaotong University School of Medicine,
Shanghai 200025, China.
Tel: +86-21-6445-3260 Fax: +86-21-6466-3160
E-mail: wangyf@shsmu.edu.cn;
Prof. Chen Xu, Department of Histology and Embryology, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
Tel: +86-21-6384-6590 ext. 776435 Fax: +86-21-6466-3160
E-mail: chenx@shsmu.edu.cn
Received 2006-07-21 Accepted 2006-12-12
DOI: 10.1111/j.1745-7262.2007.00260.x
1 Introduction
Mammalian spermatozoa are produced in the testis,
and they progressively acquire their functional
capacities of forward motility as they migrate through the
epididymis. Many changes, both morphological and biochemical, take place during this development and
maturation process. These changes are the result of
protein interactions within germ cells and between germ cells
and the microenvironment of the testis and epididymis.
In other words, spermatogenesis and sperm maturation
are regulated not only by gene expression in the germ cells
but also by the microenvironment which is created and
maintained through the precise expression of a series of
genes in the testis and epididymis. To elucidate the
molecular basis underlying sperm development and maturation,
many genes which are specifically or highly expressed in
the testis and/or the epididymis have been identified in the
past few years [1_4] and the cystatin-related epididymal
and spermatogenic (Cres) gene is among them [5].
The Cres gene encodes a protein which exhibits
substantial homology with members of the family 2 cystatins
in the cystatin superfamily of cysteine proteinase
inhibitors [5]. This homology includes four highly conserved
cysteine residues in exact alignment as that in the cystatins
as well as other regions of sequence characteristic of the
cystatins [6,7]. Despite of all the similarities, the Cres
protein lacks two of the three motifs thought to be
necessary for the inhibition of cysteine proteinases [7, 8].
Therefore, Cres protein may not function as a typical
cystatin. Furthermore, unlike the ubiquitous expression
of the members of the cystatin family, Cres gene shows
a highly tissue-specific expression pattern. Cres mRNA
is mainly expressed in postmeiotic germ cells and the
proximal caput epididymis with less expression in
anterior pituitary gonadotrophs and corpus luteum in the ovary
[5, 9_11]. These observations suggest that Cres protein
defines a new subgroup in the family 2 cystatins and
may perform a unique function distinct from that of the
classic cystatin proteins.
The purpose of this study is to investigate the spatial
and temporal expression pattern of Cres gene in mouse
testis and epididymis during postnatal development. By
using a more sensitive method, this study further
characterizes the age-dependent change of Cres mRNA
expression.
2 Materials and methods
2.1 Animals
Intact male BALB/c mice were purchased from the
Animal Center of the Chinese Academy of Sciences (Shanghai, China), and were divided into 8 groups
(n = 3) according to their postnatal age (14, 20, 22, 28, 35,
49, 70 and 420 days). The testes and epididymides were
removed immediately after the animals were killed by
cervical dislocation. The tissues were either placed in
RNAlater (QIAGEN, Hilden, Germany) until used for QuantiGene assay, or fixed in Bouin's solution for
indirect immunofluorescence.
2.2 QuantiGene assay
Three sets of oligonucleotide probes were denoted
capture extenders (CEs), label extenders (LEs), and
blocking probes (BLs), respectively. The probe sets
specific for the Cres and β-actin (constitutive control)
mRNAs were designed and synthesized by Genospectra (Fremont, CA,
USA). The common sequence of the two Cres transcripts was utilized for the probe design.
The mRNAs were quantified using the QuantiGene Explore kit (Genospectra, Fremont, CA, USA) as per the
manufacturer's protocol. Briefly, the testes and epdidymides
were homogenized in lysis buffer (600 µL/10 mg tissue),
and 10 µL of the tissue homogenate was added to each
well of a 96-well Capture Plate with 80 µL lysis working
reagent and 10 µL combined probe sets. The probes
were allowed to hybridize to specific mRNAs at 53ºC
for 18 h. Excess probes were removed by rinsing with
wash buffer. The captured mRNAs were then hybridized with branched DNA (bDNA) amplifier and alkaline
phosphatase-labeled probe subsequently at 53ºC for 60
min. After incubation with the substrate solution at 53ºC
for 30 min, luminescence was measured with a
Perkin-Elmer EnVision luminometer (Perkin-Elmer, Wellesley,
MA, USA). All values are the ratio of relative light units
(RLU) of the Cres to that of the β-actin, and data are
expressed as the mean ± SE. Data are representative of
three independent experiments.
2.3 Indirect immunofluorescence
Following fixation and embedding, tissue sections of
6 µm were cut. The sections were microwaved for 5
min in 0.01 mol/L citric acid buffer, and then incubated
in 5% bovine serum albumin (BSA) for 60 min at room
temperature to block nonspecific binding. The 1:400
diluted polyclonal rabbit anti-mouse CRES antiserum [9]
was applied and incubated overnight at 4ºC. Negative
control sections were incubated with preimmune rabbit
serum (1:400) instead of the antiserum. The sections
were rinsed in PBS and then incubated with a 1:100
diluted FITC-conjugated goat anti-rabbit IgG (Jackson
Immunoresearch, West Grove, PA, USA) for 1 h at room
temperature. Following PBS washes, the slides were
inverted onto coverslips containing glycerol/PBS. After
taking photographs with an LSM-510 laser scanning confocal microscope (Carl Zeiss, Oberkochen, Germany),
the immunofluorescence-stained sections were re-stained
with hematoxylin-eosin for cell discrimination.
3 Results
3.1 Cres mRNA expression
QuantiGene assay uses a signal-amplification probe
to quantify mRNA without RNA purification and reverse
transcription, and generate data which are consistent,
reproducible and less prone to possible artifacts [12].
Since the two transcripts of the Cres gene showed
similar expression patterns [13], common sequence between
them was used for the probe design. Therefore, the
quantification is a sum of the two transcripts.
QuantiGene assay showed that in the testis, a very
low level of Cres mRNA was detected on day 20. The
expression of Cres increased gradually thereafter, with
significant increase from day 22 to day 28 (15 fold), and
reached a peak by day 70 (Figure 1A). In the epididymis,
a similar expression pattern was obtained except that the
most dramatic increase occurred from day 28 to day 35
(4.5 fold) and remained elevated from day 70 to day 420
(Figue 1B). QuantiGene assay still detected a steady
increase of Cres mRNA after day 35 in both the testis and
epididymis, which was not observed by the less
sensitive RT-PCR method[13].
3.2 Cres protein expression
In mouse testis, no Cres-positive cells could be
detected from day 14 to day 20 (data not shown). On day
22, elongating spermatids could first be found in a few
seminiferous tubules and these cells were identified as
Cres-positive (Figure 2A, yellow arrow). However,
non-specific positive cells could also be observed on the
negative control sections at this stage (Figure 2B), and these
cells proved to be preleptotene spermatocytes when the
sections were restained with hematoxylin and eosin. The
non-specific positive staining of preleptotene
spermatocytes also appeared on day 28 (Figure 2D), but
disappeared from day 35 on (Figure 2F, H). Moreover,
non-specific staining was also found in the testicular
interstitium (Figure 2B, D, F, H). Cres-positive cells increased
dramatically from day 28 to day 35, and continued to
increase till day 49 due to the increasing number of the
elongating spermatids (Figure 2C, E, G). From day 49
to day 420, the number of Cres-positive cells was
almost stable. Although the number of positively-stained
cells was closely related to the age of the mouse, the
stain intensity of Cres protein was mainly correlated with
the stages of the cycle of the seminiferous epeithelium
rather than the developmental stages of the mouse. That
is, Cres protein was weakly positive in early elongating
spermatids of stages IX_XI, and showed strong positive
staining in mid-elongating spermatids of stages XII_V,
then the stain intensity became weak again in late
elongating spermatids of stages VI_VIII (Figure 3).
In mouse epididymis, no Cres-positive cells could be
observed on day 14 when the epididymis consisted of
low columnar undifferentiated cells (data not shown).
From day 20 to day 28, weakly stained Cres-positive
cells were identified in the proximal caput epididymal
epithelium, and the Cres protein was localized to the
supranuclear region of the principal cells (Figure 4A, B).
No positive staining was detected throghout the
remainder of the epididymis. Cres protein expression increased
dramatically from day 28 to day 35, then the high
expression level maintained till day 420 (Figure 4C, E, G,
H). Moreover, a region-specific expression pattern of
Cres protein was observed from day 35 on, that is, Cres
protein was restricted to the principal cells of the
proximal caput epididymis (Figure 4C, G) as well as part of
the cells and luminal fluid of the midcaput
epididymis(Figure 4E, H). By the distal caput epididymis, the Cres
protein had disappeared from both the tissue and luminal
fluid and was not detected throughout the remainder of
the epididymis (Figure 4I, J). No positive staining was
observed on any of the negative control sections (Figure
4D, F).
4 Discussion
In this study, we demonstrated that Cres mRNA was
first detected in mouse testis on day 20 of postnatal age
when round spermatids first appeared in the
seminiferous tubules [14]. Cres protein was first detected on day
22 when early elongating spermatids began to emerge.
These results suggest that a delay exists between
Cres gene transcription and translation. This is also the case
in the adult mouse testis where Cres mRNA is mainly
transcribed in round spermatids, while Cres protein is
synthesized in elongating spermatids [9]. This is not
surprising as all mRNA required for the later stages of
spermatogenesis must be produced earlier and is stored
until needed_known as translational delay. Hsia
et al [15] found Cres mRNA was first detected on day 22 in
mouse testis when round spermatids first appeared. It
seemed that Cres gene transcription always corresponds
with the appearance of round spermatids rather than the
different birth date among various strains of mice. The
Cres mRNA increased dramatically from day 22 to day
28, whereas the predominant increase of Cres protein
occurred from day 28 to day 35. These results
reconfirmed the translational delay. Non-specific
immunofluorescence-staining in preleptotene spermatocytes was
observed from day 14 to day 28. Cornwall et
al. [9] found the Cres antibody cross-reacted with a 24 kDa
protein when conducting Western blot analysis. However,
Western blot using preimmune serum did not detect the
Cres protein and the 24 kDa protein. So we don't think
the non-specific staining was caused by the 24 kDa protein.
Moreover, the non-specific staining totally disappeared
after day 35. This is probably because the gene
expression and protein synthesis in early meiotic cells or
spermatogonia are different at various postnatal stages. Our
results also showed that with the proliferation of germ
cells from puberty (day 35-49) to adult (day 70), a
further increase of Cres mRNA and its protein was detected.
No drastic decrease of Cres gene expression was
observed in 420-day-old mouse testis. However, we can
not rule out the possibility that a further decline of Cres
mRNA and its protein might be observed if older mice
are examined.
Indirect immunofluorescence also found that although
the number of Cres-positive cells varied a lot at different
ages, the staining intensity was mainly dependent on the
stages of the cycle of the seminiferous epithelium rather
than the developmental stages of the mouse. This
stage-specific expression was consistent with previous
studies in adult mouse testis [9]. According to Syntin
et al [16], the Cres protein is packaged into the sperm acrosomes
of late stage elongating spermatids and then is released
during the acrosome reaction at the time of fertilization.
The age-dependent and stage-specific expression pattern
of the Cres gene strongly suggested its involvement in
spermatogenesis, especially in the process of
spermiogenesis since Cres protein expression corresponds
approximately with the onset of spermatid elongation.
In mouse epididymis, the Cres gene also showed an
obvious age-dependent expression manner. Different
from the transcription-translation delay in the testis, the
expression of the Cres protein in the epididymis closely
parallels the expression of the Cres mRNA. Both of the
mRNA and the protein were first detected on day 20,
and the most dramatic increase happened from day 28 to
day 35. It should be noted that from day 35 on, the
spermatozoa produced in the testis continuously pass
through the epididymis to acquire their forward motility
and fertilizing capacity. And it is on day 35 that the Cres
protein began to show a more distinct region-specific
localizaion. Cres-positive staining was detected not only
in the proximal caput epididymal epithelium, but also in
the luminal fluid of the midcaput. However, the Cres
protein totally disappeared from the distal caput epididymis.
The staining was not likely caused by break down of dead
spermatozoa or phagocytosis of these cells by the
epididymal epithelium, because dead spermatozoa existed
throughout all parts of the epididymis whereas the
staining was region-specific. Taken together, the
age-dependent and region-specific expression pattern of the
Cres gene implied its importance in sperm maturation because
the microenvironment of the caput region has been shown
to be essential for sperm to acquire their forward
motility [17].
Our results, together with previous reports, suggested
the Cres protein may possess two different functions:
one within the elongating spermatids and another within
the epididymis. The Cres protein could thus be
considered a "moonlighting" protein. Moonlighting proteins have
been recently described as proteins that possess multiple
functions and subcellular localizations. Many of
these proteins have been reported. For example, the selenoprotein
phospholipid hydroperoxide glutathione peroxidase (PHGPx) exists as a soluble peroxidase in spermatids
and also as a structural protein on the tail midpiece of the
fully differentiated spermatozoa [18]. Thus, depending
upon its localization within the elongating spermatids or
in the caput epididymis at various postnatal stages, the
Cres protein may play multiple roles as do other
moonlighting proteins.
In conclusion, the Cres gene shows a specific
age-dependent expression pattern in mouse testis and
epididymis on both the mRNA and protein level, which may
indicate its dual functions of the Cres gene during
spermatogenesis and its involvement in sperm maturation.
Acknowledgment
This work was supported by the National Natural
Sciences Foundation of China (No. 30070391), the
Science and Technology Development Foundation of
Shanghai Population and Family Planning Commission (No.
03JG 05009), and the Science and Technology Foundation of Shanghai Jiao Tong University.
References
1 Kitajima K, Matsumoto K, Tahara M, Takahashi H, Nakamura
T. A newly identified AMSH-family protein is specifically
expressed in haploid stages of testicular germ cells. Biochem
Biophys Res Commun 2003; 309: 135_42.
2 Looman C, Mark C, Abrink M, Hellman L.
MZF6D, a novel KRAB zinc-finger gene expressed exclusively in meiotic male
germ cells. DNA Cell Biol 2003; 22: 489_96.
3 Li P, Chan CH, He B, So SC, Chung YW, Shang Q,
et al. An antimicrobial peptide gene found in the male reproductive
system of rats. Science 2001; 291: 1783_5.
4 Hopkins KM, Wang X, Berlin A, Hang H, Thaker HM,
Lieberman HB. Expression of mammalian paralogues of
HRAD9 and Mrad9 checkpoint control genes in normal and
cancerous testicular tissue. Cancer Res 2003; 63: 5291_8.
5 Cornwall GA, Orgebin-Crist MC, Hann SR. The
CRES gene: a unique testis-regulated gene related to the cystatin family is
highly restricted in its expression to the proximal region of the
mouse epididymis. Mol Endocrinol 1992; 6: 1653_64.
6 Shoemaker K, Holloway JL, Whitmore TE, Maurer M,
Feldhaus AL. Molecular cloning, chromosome mapping and
characterization of a testis-specific cystatin-like cDNA,
cystatin T. Gene 2000; 245: 103_8.
7 Cornwall GA, Hsia N, Sutton HG. Structure, alternative
splicing and chromosomal localization of the cystatin-related
epididymal spermatogenic gene. Biochem J 1999; 340: 85_93.
8 Turk V, Bode W. The cystatins: protein inhibitors of cysteine
proteinases. FEBS Lett 1991; 285: 213_9.
9 Cornwall GA, Hann SR. Transient appearance of CRES
protein during spermatogenesis and caput epididymal sperm
maturation. Mol Reprod Dev 1995; 41: 37_46.
10 Sutton HG, Fusco A, Cornwall GA. Cystatin-related
epididymal spermatogenic protein colocalizes with luteinizing
hormone-beta protein in mouse anterior pituitary gonadotropes.
Endocrinology 1999; 140: 2721_32.
11 Hsia N, Cornwall GA. Cres2 and Cres3: new members of the
cystatin-related epididymal spermatogenic subgroup of
family 2 cystatins. Endocrinology 2003; 144: 909_15.
12 Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS,
Khvorova A. Rational siRNA design for RNA interference.
Nat Biotechnol 2004; 22: 326_30.
13 Yuan Q, Xu C, Zhang X, Chen H, Wang Y. Expression of the
cystatin-related epididymal spermatogenic gene in mouse
testes and epididymis at different postnatal stages. Zhonghua
Nan Ke Xue 2004; 10: 168_71.
14 Katz D, Niederberger C, Slaughter GR, Cooney AJ.
Characterization of germ cell-specific expression of the orphan nuclear
receptor, germ cell nuclear factor. Endocrinology 1997; 138:
4364_72.
15 Hsia N, Brousal JP, Hann SR, Cornwall GA. Recapitulation
of germ cell- and pituitary-specific expression with 1.6 kb of
the cystatin-related epididymal spermatogenic
(Cres) gene promoter in transgenic mice. J Androl 2005; 26: 249_57.
16 Syntin P, Cornwall GA. Immunolocalization of CRES
(Cystatin-related epididymal spermatogenic) protein in the
acrosomes of mouse spermatozoa. Biol Reprod 1999; 60:
1542_52.
17 Zhou CX, Zhang YL, Xiao L, Zheng M, Leung KM, Chan
MY, et al. An epididymis-specific beta-defensin is important
for the initiation of sperm maturation. Nat Cell Biol 2004;
6:458_64.
18 Ursini F, Heim S, Kiess M, Maiorino M, Roveri A, Wissing J,
et al. Dual function of the selenoprotein PHGPx during sperm
maturation. Science 1999; 285:1393_6. |